The Blood Screening Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Blood Screening Market?
The market size of blood screening has been on a solid upward trend recently. It is projected to increase from $3.15 billion in 2024 to $3.45 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Blood Screening Industry?
The blood screening market is predicted to expand significantly, reaching a worth of $5.37 billion in 2029. The market is also forecasted to grow at a compound annual growth rate (CAGR) of 11.7%.
Download Your Free Sample of the 2025 Blood Screening Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Blood Screening Market?
The key drivers in the blood screening market are:
• The development of healthcare infrastructure
• Increased public health awareness programs
• Advancements in infectious disease diagnostics
• Global health concerns and preparedness for pandemics
Global Market Segmentation: Identifying Major Blood Screening Industry Segments
The blood screening market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Software And Services
2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)
3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)
Pre-order the 2025 Blood Screening Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Blood Screening Market?
The key trends in the blood screening market are:
• There is an increasing trend of infectious diseases.
• Automation and efficiency improvements in blood screening are emerging.
• The demand for blood transfusion is on the rise.
• There is a growing focus on transfusion safety and pathogen detection research.
Who Are the Top Competitors & Leading Players in the Blood Screening Market?
Major companies in the blood screening market are:
• Abbott Laboratories
• Grifols S.A.
• Becton Dickinson and Company
• F. Hoffmann-La Roche AG
• bioMérieux S.A.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics Inc.
• Beckman Coulter Inc.
• Siemens Healthineers AG
• GE Healthcare
• DiaSorin S.p.A.
• Merck KGaA
• PerkinElmer Inc.
• Bio-Techne Corporation
• Roche Diagnostics GmbH
• Danaher Corporation
• Sysmex Corporation
• Natera Inc.
• GenMark Diagnostics Inc.
• QIAGEN N.V.
• Hologic Inc.
• Luminex Corporation
• Trinity Biotech plc
• Fujirebio Inc.
• OraSure Technologies Inc.
• Immunetics Inc.
• Accelerate Diagnostics Inc.
• Cepheid Inc.
• T2 Biosystems Inc.
• Haemonetics Corporation
• HTG Molecular Diagnostics Inc.
• Verax Biomedical Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the blood screening market in 2024
